Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 7, 2018

View Archived Issues

Study gives clues to mitigating pneumonia risk after flu

Structural tuning yields tuberculosis fighter

CRISPR bad news, but with a fix

Crunching the data on CRP

Silencing SOD1 with miRNA for SOD1-linked ALS

New insights into microexon regulation

Fat and fibroblasts

GlycoMimetics initiates phase III trial of uproleselan in relapsed/refractory AML

YC-6 exhibits safety and tolerability in first-in-human study

Deubiquitinase Usp12 is neuroprotective in Huntington's disease neurons

Discovery of new envelope-based antigen that triggers potent humoral responses against HIV-1

INS-3001 demonstrates efficacy in rat model of vascular calcifications

Enesi and Sementis collaborate on solid dose vaccine development

Corcept Therapeutics enrolling participants in phase III study of relacorilant

CF-MEV-132 reduces lung damage in rat model of hyperoxia-induced bronchopulmonary dysplasia

Platelet-targeting vaccine may reduce post-stroke blood clot risk

MC-RG19, a novel 5-HT7 receptor antagonist, reduces hypothermia in rats

Upadacitinib demonstrates efficacy in treating ulcerative colitis

Universita di Pisa patents AMPK subunit alpha-2 activators

Novintum Biotechnology presents new doxycycline derivatives for cancer

FDA clears IND for herpes zoster vaccine candidate CRV-101

FDA approves Empliciti plus pomalidomide and dexamethasone for relapsed/refractory multiple myeloma

DSMB recommends discontinuation of phase III study of PREOB for osteonecrosis

Secarna and MetP to codevelop transnasal antisense oligonucleotide-based CNS therapeutics

Sosei collaborates with DyNAbind to accelerate GPCR drug discovery

Tonix presents retrospective analyses from phase III HONOR study of Tonmya in PTSD

BioNTech and University of Pennsylvania collaborate on mRNA-based vaccines for infectious disease

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026